Director, Global HEOR – Top Boston Pharma seeks Prospective Study exp. to work on 1s-in-Class “Game Changer” | RETAINED SEARCH
Cornerstone Search Group’s HEOR/Market Access Practice is pleased to have been retained by a leading Boston-area pharmaceutical company renowned for operating at the forefront of scientific innovation, successfully launching multiple breakthrough medicines, and having top-notch talent. They are seeking a high EQ HEOR professional for a newly created critical Global HEOR position will focus on the US and international launches of a high-profile, “game-changing”, first-in-class asset projected to be a multi-blockbuster, particularly on Prospective Studies, to support the value of this and other assets for reimbursement and healthcare payers across all product lifecycle stages.
4 HIGHLY ATTRACTIVE FEATURES:
- High-Profile Impact: This is a critical global HEOR role, as this team’s strategy and output will significantly determine whether this first-in-class asset will have its anticipated societal impact.
- Stable and Growing Company: In an era of instability and staff cutbacks by companies of all sizes, our client’s scientific and strategic acumen has led to continued growth, providing organizational stability and demonstrating career progression (including for this hiring manager).
- Strong HEOR Leadership: Our client’s HEOR department has steady, proven, high EQ leadership.
- Attractive to Directors: Our client offers highly competitive compensation, LTI, relocation, and sign-on bonus programs along with a highly regarded department leader, and a demonstrated history of internal career growth. This position can be attractive to very experienced HEOR professionals.
RESPONSIBILITIES IN A NUTSHELL:
- Lead and execute the US/Global HEOR strategy for prospective non-interventional research, which is aligned with the pain program strategy.
- Represent HEOR perspectives in cross-functional forums and with external partners, aligning research with program and business objectives.
- Lead with vendor support, the development of protocols, investigator brochures, informed consent forms (ICFs), case report forms (CRFs), statistical analysis plans, and technical reports.
- Lead Study Execution Teams (SETs), ensuring efficient, high-quality study execution.
- Oversee data analysis, interpretation, scientific rigor, and communication of results, ensuring contextually relevant.
- Lead the development of presentations, manuscripts, and other dissemination activities
- Partner with internal stakeholders, such as Medical Affairs, to ensure alignment in study design, execution, and dissemination.
- Represent the company externally with investigators, collaborators, and scientific experts in protocol development and study conduct.
LOCATION: Boston Metro Area (on-site or hybrid). Three days/week on-site is required.
RELOCATION: Full relocation assistance is available.
COMPENSATION: Competitive base salary and annual bonus with an aggressive LTI program, generous PTO, and excellent benefits.
DESIRED SKILLS/ QUALIFICATIONS / EXPERIENCES / BEHAVIORS:
- MA/MS, MPH, PharmD, PhD, or MD
- 5+ years of relevant experience in health economics, outcomes research, clinical research, or observational studies in academia, industry, or a related field.
- Proven experience leading the design, execution, and analysis of prospective and non-interventional studies, including site feasibility, case report form development, and recruitment.
- Strong knowledge of GCP, biostatistics, clinical research methods, and study design.
- Experience preparing publications and presenting scientific findings.
- Strategic thinker who can connect evidence generation to business and clinical priorities.
- Hands-on project leader with strong execution skills and attention to detail.
- Our client is open to therapeutic areas of experience.
- High emotional intelligence ( EQ ) coupled with strong communication, presentation, and influencing skills across internal and external stakeholders.
CONTACT:
Rita Boyle | Partner
E: rboyle@cornerstonesg.com
P: 973.656.0220 x735
LinkedIn: https://www.linkedin.com/in/ritaboyle
or
Corey S. Ackerman, JD | Senior Partner
E: cackerman@cornerstonesg.com
P: 973.656.0220 x 716
LinkedIn: www.linkedin.com/in/coreyackerman
CORNERSTONE SEARCH GROUP - Life Sciences Executive Search
1200 Morris Turnpike, Suite 3005 | Short Hills, NJ (USA)
Cornerstone Search Group, recognized by Forbes as one of the "Top 100 Executive Search Firms" and by Hunt Scanlon as one of the "Top 50 Healthcare & Life Sciences Executive Search Firms", is a Life Sciences Executive Search firm that helps companies based around the world, ranging from startup biotechs to Top 10 pharma, to find, attract, and hire talent for their US and globally based leadership positions (CxO and xVP levels) as well as their critical Director-level roles.
Representative Retained Search Assignments:
- CEO | specialty pharma start-up
- CEO | regenerative medicine start-up
- US CEO | established European small pharma
- President/US Commercial Head | Generics Pharma
- CMO | late-stage public biotech
- CMO | mid-size pharma
- CSO | mid-size global biotech
- SVP, Head of Global Medical Affairs | mid-size oncology company
- SVP, Head of Global Clinical Development | multi-TA mid-size pharma
- SVP, Head of Global Regulatory Affairs | late-stage Israeli biotech
- Global Head, Oncology R&D | mid-size European pharma
- Group VP, Global Commercial Head | API Business Unit | Indian pharma
- VP, Data Science RWE | Top 5 Pharma
- VP, Head of Regulatory Affairs | Boston Biotech
- VP, US Head of Regulatory Affairs | Top 20 Pharma
- VP, Head of R&D Operations | Boston biotech
- VP, Head of HEOR (Health Economics & Outcomes Research | Top CNS specialty pharma
- VP, Head of US HEOR & RWE | Top 5 Pharma
- VP, Head of Real-World Evidence | Top 5 pharma
- VP, Head of US HEOR | Top Oncology Pharma
- ED, Head of HEOR | Top West Coast Pharma
- VP, Head of Global Market Access | Top Oncology Specialty Pharma
- VP, Head of US Market Access | High-profile late-stage biotech
- VP, Head of US Market Access | West Coast Late-Stage Public Biotech
- VP, Head of Heme/Onc Clinical Research | Public oncology biotech
- VP, Head of Clinical Development | late-stage anti-infectives UK pharma
- VP, Head of Global Drug Safety & PV | Chinese oncology biotech
- ED, Head of Clinical Operations | British VC-backed biotech
- ED, Global Commercial Strategy Franchise Head | Top rare disease Boston pharma
- ED, Head of Global Clinical Pharmacology | Public oncology biotech
- ED, Head of Global HEOR | Large US Pharma
- Head, Patient Advocacy | European commercial-stage rare disease biotech
- Medical Directors (Director/SD/ED levels) in Translational Medicine / Clinical Development / Medical Affairs / Drug Safety: 75+ retained assignments
- HEOR/RWE/Market Access (AD/Director/SD/ED levels): 100+ retained assignments
Cornerstone’s Privacy Policy: Cornerstone Search Group considers all inquiries, resume submissions, and any other personal information submitted to us as confidential information. This information will not be shared with any parties outside of Cornerstone Search Group without your prior permission.
Keywords: GHEOR “Health Economics” “Real-World Evidence” “prospective studies” “Outcomes Research” rare disease HEOR GHEOR GHE
